Search Results - "Novak, Barbara L."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro by Hugger, Erin D, Novak, Barbara L, Burton, Philip S, Audus, Kenneth L, Borchardt, Ronald T

    Published in Journal of pharmaceutical sciences (01-09-2002)
    “…P-glycoprotein (P-gp), a multidrug resistance (MDR) protein encoded by the MDR1 gene in humans, is responsible for the efflux of structurally diverse drugs…”
    Get more information
    Journal Article
  2. 2

    Erythropoietin‐Induced Hypertensive Urgency in a Patient with Chronic Renal Insufficiency: Case Report and Review of the Literature by Novak, Barbara L., Force, Rex W., Mumford, Brett T., Solbrig, Ronald M.

    Published in Pharmacotherapy (01-02-2003)
    “…Hypertension is a potentially dangerous side effect of erythropoietin treatment; however, extreme elevations in blood pressure are rare. A 75‐year‐old woman…”
    Get full text
    Journal Article
  3. 3

    Detriments of tPA for acute stroke in routine clinical practice by Novak, Barbara L, Force, Rex W

    Published in The Journal of family practice (01-02-2003)
    “…Under optimal conditions, tissue plasminogen activator (tPA) may be a viable option for treatment of acute ischemic stroke; however, this study showed that…”
    Get full text
    Journal Article
  4. 4